Last Updated: 31-07-2025 | Format: PDF | Report ID:20523 | Author: Clara
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,370 Million |
| What is the projected market size by 2035? | $2,230 Million |
| What is the market CAGR from 2025 to 2035? | 5.0% |
| Which region dominates the market? | United States (69%) |
| Which product/service type dominates the market? | Blood Tests (38%) |
| Which application leads the market? | Dry Blood Spot Screening (31%) |
| Who are the major buyers? | Hospitals (51%), Diagnostic Centers (22%) |
| What are the key market growth drivers? | Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes; Increased integration of advanced technologies like tandem mass spectrometry and next-gen sequencing is enabling faster and more accurate detection |
| What are the major market challenges? | Complex reimbursement models and variations in insurance policies challenge universal adoption of newborn screening; Ensuring consistency and accuracy across decentralized testing sites remains a challenge amid rising demand |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| What is the forecast period? |
| 2026–2035 |
| Who are the key market players? | PerkinElmer Inc.,Natus Medical Incorporated,Bio-Rad Laboratories Inc.,Trivitron Healthcare,Masimo Corporation,Medtronic Plc,Thermo Fisher Scientific Inc.,Baebies Inc.,Demant A/S,Centogene N.V.,BioVision Technologies,Agilent Technologies Inc.,BioTek Instruments Inc.,AB Sciex,MedScreen Inc. |
Global Active Pharmaceutical Ingredient Market: by Type (Synthetic, Biotech, HPAPI, Highly Potent, Generic, Branded), Application (Cardiology, Oncology, Neurology, Endocrinology, Anti-infectives, Others), Distribution Channels (Direct Sales, Distributors/Wholesalers, E-commerce, Specialty Pharmacies, Hospitals, Retail Pharmacies), Technology (Traditional, Biotechnology, Fermentation, Chemical Synthesis, High-Throughput Screening, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market Market: by Type (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Treatment, Prognosis, Screening, Research, Others), Distribution Channels (Hospitals, Diagnostic Centers, Research Laboratories, Specialty Clinics, Pharmacies, Online Channels), Technology (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, Surgery, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
US Early Stage Cancer Market Market: by Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Other Cancers), Application (Diagnosis, Screening, Monitoring, Prognosis, Treatment Planning, Other Applications), Distribution Channels (Hospitals, Diagnostic Centers, Research Institutes, Retail Pharmacies, Online Providers, Others), Technology (Imaging, Molecular Diagnostics, Genomics, Biomarker Testing, Others), Organization Size (Small, Medium, Large) and By US Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America HLA Typing Market Market: by Type (Molecular Assays, Non-Molecular Assays), Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025